Literature DB >> 2645781

Insulin degradation products from perfused rat kidney.

W C Duckworth1, F G Hamel, J Liepnieks, D Peavy, B Frank, R Rabkin.   

Abstract

The kidney is a major site for insulin metabolism, but the enzymes involved and the products generated have not been established. To examine the products, we have perfused rat kidneys with insulin specifically iodinated on either the A14 or the B26 tyrosine. Labeled material from both the perfusate and kidney extract was examined by Sephadex G50 and high-performance liquid chromatography (HPLC). In perfusate from a filtering kidney, 22% of the insulin-sized material was not intact insulin on HPLC. With the nonfiltering kidney, 10.6% was not intact insulin. Labeled material from HPLC was sulfitolyzed and reinjected on HPLC. By use of 125I-iodo(A14)-insulin, almost all the degradation products contained an intact A-chain. By use of 125I-iodo(B26)-insulin, several different B-chain-cleaved products were obtained. The material extracted from the perfused kidney was different from perfusate products but similar to intracellular products from hepatocytes, suggesting that cellular metabolism by kidney and liver are similar. The major intracellular product had characteristics consistent with a cleavage between the B16 and B17 amino acids. This product and several of the perfusate products are also produced by insulin protease suggesting that this enzyme is involved in the degradation of insulin by kidney.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2645781     DOI: 10.1152/ajpendo.1989.256.2.E208

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  4 in total

1.  Insulin-degrading enzyme modulates the natriuretic peptide-mediated signaling response.

Authors:  Luis A Ralat; Qing Guo; Min Ren; Todd Funke; Deborah M Dickey; Lincoln R Potter; Wei-Jen Tang
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

2.  Protein degradation in cultured fetal hepatocytes. Absence of an inhibitory effect of insulin.

Authors:  D E Peavy; D C DeSante
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

3.  Insulin-degrading enzyme in a human colon adenocarcinoma cell line (Caco-2).

Authors:  J P Bai; M J Hsu; W T Shier
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

4.  Transepithelial transport of insulin: I. Insulin degradation by insulin-degrading enzyme in small intestinal epithelium.

Authors:  J P Bai; L L Chang
Journal:  Pharm Res       Date:  1995-08       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.